Patients with cancer in the urology clinic at a VA hospital in Arizona may have suffered adverse outcomes due to clinical disconnect and staff shortage.
An inspection conducted by the VA Office of Inspector General Office of Healthcare Inspections (OHI) at the Phoenix VA Health Care System identified issues related to patient access to care as well as quality of care issues at the hospital’s Urologic clinic, whcih could have resulted in adverse heath outcomes and even death for veterans with bladder and prostate cancer.
Following a preliminary review that identified staff shortages affecting thousands of patients, the OHI conducted a more exhaustive review of 3321 electronic medical records of patients referred to the clinic. About 45% of the patients experienced delays in getting new evaluations or follow-up appointments within the urology service. Additionally, 23% of the reviewed records care providers at the VA did not have timely access to patient medical records generated outside of the VA. The report interprets this as a lack of accurate data on the clinical status of these patients, indicating disconnected patient management.
Additionally, the investigation found that patients did not receive care or timely urological services to patients who needed care. Ten patients, the report says, experienced significant delays that could have affected their clinical outcome and placed the patient in the path of unnecessary harm.
The report urged the facility director at the hospital to make changes that would ensure adequate resources for timely patient care, provider access to patient records generated outside the VA system, and a review of cases that were identified as having received poor quality of care and a plan for adequate disclosure to patients and their families.
Read more here.
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More